P935: EARLY RELAPSE WITHIN 18 MONTHS (ER18) IS A POWERFUL DYNAMIC PREDICTOR FOR PROGNOSIS AND COULD REVISE STATIC RISK DISTRIBUTION IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA
Wenqiang Yan,
Jian Cui,
Jingyu Xu,
Huishou Fan,
Yan Xu,
Lugui Qiu,
Gang An
Affiliations
Wenqiang Yan
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
Jian Cui
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
Jingyu Xu
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
Huishou Fan
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
Yan Xu
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
Lugui Qiu
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
Gang An
1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China
